Valuation: Abbott Laboratories

Market Cap 178B 155B 146B 133B 249B 17,010B 249B 1,746B 673B 8,665B 667B 652B 27,961B P/E 2026 *
29.1x
P/E 2027 * 22.5x
Enterprise Value 201B 176B 165B 151B 283B 19,304B 283B 1,982B 764B 9,833B 757B 740B 31,731B EV / Sales 2026 *
4.01x
EV / Sales 2027 * 3.64x
Free-Float
86.16%
Yield 2026 *
2.51%
Yield 2027 * 2.67%
1 week+0.54%
Current month-7.13%
1 month-9.03%
3 months+15.98%
6 months-5.50%
Current year-18.15%
1 week 100.39
Extreme 100.39
104.37
1 month 100.39
Extreme 100.39
117.34
3 years 81.98
Extreme 81.98
141.08
5 years 81.98
Extreme 81.98
142
10 years 37.38
Extreme 37.38
142
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+0.54%-23.80%+1.52% 178B
+0.53%-0.26%-24.74%+3.93% 178B
+0.05%-1.89%-2.74%+14.38% 118B
+2.32%-3.04%+9.53%+71.04% 58.92B
-0.15%-1.31%-3.23%-31.89% 49.29B
-0.22%-0.37%+10.27%+42.75% 48.17B
+0.21%+5.68%+28.74%+0.46% 33.72B
+0.40%-2.82% - - 27.76B
-0.07%+2.01%+43.67%-3.19% 25.5B
+1.77%+9.57%+9.06%-13.10% 22.1B
Average +0.55%+1.65%+5.20%+9.54% 62.32B
Weighted average by Cap. +0.50%+0.95%-8.11%+9.82%

Financials

2026 *2027 *
Net sales 50.2B 43.77B 41.23B 37.55B 70.39B 4,810B 70.48B 494B 190B 2,450B 189B 184B 7,906B 54.53B 47.54B 44.78B 40.78B 76.46B 5,224B 76.55B 536B 207B 2,661B 205B 200B 8,587B
Net income 6.3B 5.5B 5.18B 4.71B 8.84B 604B 8.85B 61.99B 23.89B 308B 23.68B 23.15B 993B 7.98B 6.96B 6.55B 5.97B 11.19B 764B 11.2B 78.46B 30.24B 389B 29.97B 29.3B 1,256B
Net Debt 23.94B 20.87B 19.66B 17.9B 33.57B 2,293B 33.61B 235B 90.74B 1,168B 89.92B 87.93B 3,770B 20.96B 18.27B 17.21B 15.67B 29.39B 2,008B 29.42B 206B 79.44B 1,023B 78.72B 76.98B 3,300B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Date Price Change
21/09/26 $103.15 +0.60%
18/09/26 $102.53 +0.28%
17/09/26 $102.24 -0.12%
16/09/26 $102.36 +0.35%
15/09/26 $102.00 -1.08%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
102.61USD
Average target price
120.26USD
Spread / Average Target
+17.20%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!